Chari A - Search Results

1

Proteasome inhibition and its therapeutic potential in multiple myeloma.

Chari A, Mazumder A, Jagannath S. Chari A, et al. Biologics. 2010 Sep 28;4:273-87. doi: 10.2147/BTT.S3419. Biologics. 2010. PMID: 21116326 Free PMC article.

2

Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.

Dong H, Yang HS, Jagannath S, Stephenson CF, Brenholz P, Mazumder A, Chari A. Dong H, et al. Among authors: chari a. Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):366-74. doi: 10.1016/j.clml.2012.05.003. Epub 2012 Jun 1. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22658896

3

Safety and efficacy of triplet regimens in newly diagnosed light chain amyloidosis.

Chari A, Barley K, Jagannath S, Osman K. Chari A, et al. Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):55-61. doi: 10.1016/j.clml.2012.09.011. Epub 2012 Oct 24. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23098888

4

Misdiagnosis of non-hodgkin lymphoma as multiple myeloma.

Barley K, Harris JA, Diefenbach C, Jagannath S, Chari A. Barley K, et al. Among authors: chari a. J Clin Oncol. 2012 Dec 10;30(35):e364-7. doi: 10.1200/JCO.2012.43.0504. Epub 2012 Oct 29. J Clin Oncol. 2012. PMID: 23109698 No abstract available.

5

A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.

Ragupathi L, Najfeld V, Chari A, Petersen B, Jagannath S, Mascarenhas J. Ragupathi L, et al. Among authors: chari a. Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):175-9. doi: 10.1016/j.clml.2012.09.010. Epub 2012 Nov 15. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23168212 Review. No abstract available.

6

Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma.

Chari A, Pri-Chen H, Jagannath S. Chari A, et al. Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):333-7. doi: 10.1016/j.clml.2012.12.010. Epub 2013 Jan 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23313067 No abstract available.

7

A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.

Chepovetsky J, Chari A, Jagannath S, Ramanthan L. Chepovetsky J, et al. Among authors: chari a. Clin Chim Acta. 2013 Oct 21;425:233-5. doi: 10.1016/j.cca.2013.08.004. Epub 2013 Aug 13. Clin Chim Acta. 2013. PMID: 23954772

8

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, Sougnez C, Knoechel B, Gould J, Saksena G, Cibulskis K, McKenna A, Chapman MA, Straussman R, Levy J, Perkins LM, Keats JJ, Schumacher SE, Rosenberg M; Multiple Myeloma Research Consortium; Getz G, Golub TR. Lohr JG, et al. Cancer Cell. 2014 Jan 13;25(1):91-101. doi: 10.1016/j.ccr.2013.12.015. Cancer Cell. 2014. PMID: 24434212 Free PMC article.

9

Risk stratification in multiple myeloma, part 1: characterization of high-risk disease.

Biran N, Jagannath S, Chari A. Biran N, et al. Among authors: chari a. Clin Adv Hematol Oncol. 2013 Aug;11(8):489-503. Clin Adv Hematol Oncol. 2013. PMID: 24518420 Review.

10

Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies.

Biran N, Jagannath S, Chari A. Biran N, et al. Among authors: chari a. Clin Adv Hematol Oncol. 2013;11(9):578-83. Clin Adv Hematol Oncol. 2013. PMID: 24518521 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters